Safety Study of Rituximab (SC) Administered in Participants With CD20+ DLBCL or CD20+ Follicular NHL Grade 1 to 3A
- Status
- COMPLETED
- Phase
- PHASE3
Clinical Trials Related to Non-Hodgkin Lymphoma
Related studies linked through entity extraction aliases.
Obinutuzumab and ICE Chemotherapy in Refractory/Recurrent CD20+ Mature NHL
- Status
- RECRUITING
- Phase
- PHASE2
Study to Investigate the Safety and Tolerability of Odronextamab in Patients With CD20+ B-Cell Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
Most Closely Matched 3rd Party Rapidly Generated LMP, BARF1 And EBNA1 Specific CTL, EBV-Positive Lymphoma (MABEL)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Brentuximab Vedotin for Relapsed/Refractory CD30-positive Non-Hodgkin Lymphomas
- Status
- COMPLETED
- Phase
- PHASE2
Carfilzomib Plus Belinostat in Relapsed/Refractory NHL
- Status
- COMPLETED
- Phase
- PHASE1
Study of 6-Thioguanine in Combination With 6-Mercaptopurine During Maintenance Therapy of Childhood Lymphoma
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
Phase II Trial to Evaluate an EBV-derived Dendritic Cell Vaccine in Autologous Stem Cell Transplant
- Status
- WITHDRAWN
- Phase
- PHASE2
PD and Safety of TG-0054 Combined With G-CSF in Multiple Myeloma, Non-Hodgkin Lymphoma and Hodgkin Disease Patients
- Status
- COMPLETED
- Phase
- PHASE2
Nelfinavir for the Treatment of Gammaherpesvirus-Related Tumors
- Status
- TERMINATED
- Phase
- EARLY_PHASE1
Romidepsin Plus Oral 5-Azacitidine in Relapsed/Refractory Lymphoid Malignancies
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Umbilical Cord Blood Transplantation Using a Myeloablative Preparative Regimen for Hematological Diseases
- Status
- TERMINATED
- Phase
- NA
A Trial of Pembrolizumab (MK-3475) in Participants With Blood Cancers (MK-3475-013/KEYNOTE-013)
- Status
- COMPLETED
- Phase
- PHASE1
Tac, Mini-MTX, MMF Versus Tac, MTX for GVHD Prevention
- Status
- COMPLETED
- Phase
- PHASE3
Pralatrexate + Romidepsin in Relapsed/Refractory Lymphoid Malignancies
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Safety and Efficacy of Revlimid® (Lenalidomide) With Mabthera® (Rituximab) in Non-Hodgkin's Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
Entecavir Versus Lamivudine for Preventing the Risk of Hepatitis B Reactivation in NHL
- Status
- UNKNOWN
- Phase
- PHASE2
Phase 1 Study of CC-486 in Japanese Subjects With Hematological Neoplasms
- Status
- TERMINATED
- Phase
- PHASE1
Bendamustine Hydrochloride, Clofarabine, and Etoposide in Treating Younger Patients With Relapsed or Refractory Hematologic Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
Study of IPI-145 in Combination With Rituximab or Bendamustine/Rituximab in Hematologic Malignancies
- Status
- COMPLETED
- Phase
- PHASE1